REGN stock news
This page provides real-time market news, earnings updates, and company announcements related to Regeneron Pharmaceuticals, Inc. (REGN).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-28 13:09 EST
Regeneron beats quarterly profit estimates on Dupixent strength
101 finance2026-01-30 12:45:28
Stocks Decline After Trump Selects Warsh as Fed Chair Nominee
101 finance2026-01-30 18:09:31
Amgen (AMGN) Q4 Preview: Key Insights Before Earnings Release
101 finance2026-02-02 03:18:33
AbbVie (ABBV) Q4 Results: Anticipated Outcomes
101 finance2026-02-03 03:30:37
Where is Regeneron Pharmaceuticals (REGN) Headed According to Analysts?
Finviz2026-02-13 15:01:04
ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down
Finviz2026-02-13 16:21:42
Ocular Therapeutix Drug Shows Promise In Eye Disorder, But Falls Short of Investor Hopes
Finviz2026-02-17 14:18:04
Ocular Therapeutix Drug Shows Promise In Eye Disorder, But Falls Short of Investor Hopes
Finviz2026-02-17 14:18:04
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?
Finviz2026-02-18 16:42:43
AtaiBeckley Appoints Michael Faerm as Chief Financial Officer
Finviz2026-02-19 12:03:41
Regeneron Pharmaceuticals announced that its Biologics License Application (BLA) for Garetosmab, a treatment for fibrodysplasia ossificans progressiva (FOP), has been accepted by the U.S. Food and Drug Administration (FDA) and granted priority review status.
老虎证券2026-02-19 12:11:51
Here's What Analysts Are Saying About Regeneron Pharmaceuticals (REGN)
Finviz2026-02-19 14:54:43
BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026
Finviz2026-02-24 11:48:47
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution
Finviz2026-02-24 12:33:44
Regeneron, Sanofi Blockbuster Dupixent Scores FDA Nod For Rare Sinus Condition
Finviz2026-02-24 18:48:46
Natera Earnings: What To Look For From NTRA
Finviz2026-02-25 03:33:07
Regeneron Gains 1.57% as FDA Decision Nears, Trading Volume Ranks 207th
101 finance2026-02-25 23:24:45
Kymera Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Finviz2026-02-26 12:03:47
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
Finviz2026-02-26 21:09:42
Intellia Rises on Q4 Earnings & Revenue Beat, Focuses on Pipeline
Finviz2026-02-27 17:18:48
Why Regeneron Pharmaceuticals (REGN) is One of the Top Gene Therapy Stocks to Buy According to Hedge Funds
Finviz2026-02-28 07:24:44
Why Regeneron Pharmaceuticals (REGN) is One of the Top Gene Therapy Stocks to Buy According to Hedge Funds
Finviz2026-02-28 07:24:44
Is Regeneron Pharmaceuticals Shares Lagging Behind the Nasdaq?
101 finance2026-02-28 08:24:15
Intellia Therapeutics, Inc. (NTLA): A Bull Case Theory
Finviz2026-02-28 15:09:06
Where is Regeneron Pharmaceuticals (REGN) Headed According to Analysts?
Finviz2026-02-13 15:01:04
ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down
Finviz2026-02-13 16:21:42
Ocular Therapeutix Drug Shows Promise In Eye Disorder, But Falls Short of Investor Hopes
Finviz2026-02-17 14:18:04
Ocular Therapeutix Drug Shows Promise In Eye Disorder, But Falls Short of Investor Hopes
Finviz2026-02-17 14:18:04
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?
Finviz2026-02-18 16:42:43
AtaiBeckley Appoints Michael Faerm as Chief Financial Officer
Finviz2026-02-19 12:03:41
Regeneron Pharmaceuticals announced that its Biologics License Application (BLA) for Garetosmab, a treatment for fibrodysplasia ossificans progressiva (FOP), has been accepted by the U.S. Food and Drug Administration (FDA) and granted priority review status.
老虎证券2026-02-19 12:11:51
Here's What Analysts Are Saying About Regeneron Pharmaceuticals (REGN)
Finviz2026-02-19 14:54:43
BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026
Finviz2026-02-24 11:48:47
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution
Finviz2026-02-24 12:33:44
Regeneron, Sanofi Blockbuster Dupixent Scores FDA Nod For Rare Sinus Condition
Finviz2026-02-24 18:48:46
Natera Earnings: What To Look For From NTRA
Finviz2026-02-25 03:33:07
Regeneron Gains 1.57% as FDA Decision Nears, Trading Volume Ranks 207th
101 finance2026-02-25 23:24:45
Kymera Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Finviz2026-02-26 12:03:47
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
Finviz2026-02-26 21:09:42
Intellia Rises on Q4 Earnings & Revenue Beat, Focuses on Pipeline
Finviz2026-02-27 17:18:48
Why Regeneron Pharmaceuticals (REGN) is One of the Top Gene Therapy Stocks to Buy According to Hedge Funds
Finviz2026-02-28 07:24:44
Why Regeneron Pharmaceuticals (REGN) is One of the Top Gene Therapy Stocks to Buy According to Hedge Funds
Finviz2026-02-28 07:24:44
Is Regeneron Pharmaceuticals Shares Lagging Behind the Nasdaq?
101 finance2026-02-28 08:24:15
Intellia Therapeutics, Inc. (NTLA): A Bull Case Theory
Finviz2026-02-28 15:09:06
REGN stock chart
REGN stock detailsREGN stock price change
On the last trading day, REGN stock closed at 770.79 USD, with a price change of -1.72% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more